Spectral AI (MDAIW) Net Income towards Common Stockholders Growth (1y) (2022 - 2026)
Spectral AI (MDAIW) Net Income towards Common Stockholders Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Spectral AI | - | - | 2.03 Mn | -227.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -227.46% |
| Dec 31, 2025 | 201.60% |
| Sep 30, 2025 | -136.17% |
| Jun 30, 2025 | -178.21% |
| Mar 31, 2025 | 183.53% |
| Dec 31, 2024 | -113.90% |
| Sep 30, 2024 | 85.85% |
| Jun 30, 2024 | 6.71% |
| Mar 31, 2024 | 11.19% |
| Dec 31, 2023 | -103.91% |
| Sep 30, 2023 | -2,697.11% |
| Jun 30, 2023 | -310.42% |
| Mar 31, 2023 | -124.77% |
| Dec 31, 2022 | 80.41% |
| Sep 30, 2022 | -106.73% |
| Jun 30, 2022 | 150.26% |
| Mar 31, 2022 | 120.76% |